Anxiety and Depression Emerge as Key Barriers Keeping Breast Cancer Survivors Out of Work

For millions of women diagnosed with breast cancer each year, surviving the disease is only the first step of a long journey. The next challenge, one that receives far less attention in oncology clinics, is returning to the ordinary rhythms of life, and few rhythms matter more than work. A new systematic review published in the Journal of Cancer Research and Clinical Oncology argues that the psychological and social dimensions of that transition, long overshadowed by clinical variables such as tumor stage and treatment regimen, may be among the most decisive factors determining whether a breast cancer survivor makes it back to her job.

The review, conducted by researchers at the University of Milan and the European Institute of Oncology, including Viktorya Voskanyan, Federico Borgogni, Chiara Marzorati and Gabriella Pravettoni, systematically searched three major scientific databases, PubMed, Embase and Scopus, for studies published between 2015 and 2025 that investigated psychosocial factors associated with return to work in the breast cancer population. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses, the internationally recognized PRISMA guidelines, and registered in advance in the PROSPERO registry, the team screened the literature and ultimately included sixteen studies in its analysis. The methodological quality of each study was assessed with a modified version of the Downs and Black checklist, a standard instrument for appraising the rigor of non-randomized research.

The central finding is striking in its clarity. Among all the psychosocial variables examined, anxiety and depression emerged as the most prominent barriers to a successful return to work. Survivors experiencing elevated levels of psychological distress were consistently less likely to resume employment, or took longer to do so, than those with better mental health. This makes intuitive sense when one considers what returning to work actually demands: sustained concentration, social interaction, the cognitive stamina to manage tasks and deadlines, and the emotional bandwidth to cope with workplace stress. Depression erodes motivation and energy, while anxiety can make even familiar professional environments feel threatening after the vulnerability of a cancer diagnosis and its treatment.

Close behind anxiety and depression in the hierarchy of obstacles came fatigue, and in particular its mental and emotional dimensions rather than simply physical tiredness. Cancer-related fatigue is one of the most common and persistent sequelae of breast cancer treatment, often lingering for months or years after chemotherapy, radiotherapy or endocrine therapy has ended. The review’s emphasis on the cognitive and emotional components of fatigue is important, because it suggests that survivors may look physically recovered while still struggling with the concentration lapses, emotional exhaustion and reduced mental resilience that modern knowledge-based jobs require. An office worker who can no longer sustain attention through a full day of meetings faces a very different barrier than one recovering from surgery alone.

The third major cluster of negative determinants involved impaired quality of life, specifically in the domains of emotional and social well-being. Quality of life instruments used in oncology research typically distinguish physical functioning from emotional role functioning, social functioning and overall mental health, and the review found that it was precisely these non-physical domains that tracked most closely with employment outcomes. Survivors whose emotional well-being had recovered were markedly better positioned to re-enter the labor market than those whose scores remained depressed, even when their physical recovery was comparable. Social well-being, which encompasses the ability to maintain relationships and feel connected to a community, also proved consequential, underscoring that work is not merely an economic activity but a fundamentally social one.

On the positive side of the ledger, the review identified a set of psychological resources that consistently facilitated work reintegration. Resilience, the capacity to adapt and recover in the face of adversity, was positively associated with returning to work, as was motivation. Perhaps most actionable from a clinical standpoint was the finding that greater return-to-work self-efficacy, meaning a survivor’s own confidence in her ability to resume and sustain employment, predicted better outcomes. This is a well-established principle from behavioral science: people who believe they can accomplish a task are more likely to attempt it, persist through setbacks and ultimately succeed. In the context of cancer survivorship, self-efficacy is not a fixed trait but something that can be cultivated through counseling, gradual exposure to work demands and successful early experiences.

Two further protective factors rounded out the picture: perceived support and positive body image. Perceived support refers to a survivor’s subjective sense that she is surrounded by people, whether family, friends, colleagues or health professionals, who are willing and able to help. Breast cancer and its treatments frequently alter a woman’s body in visible ways, through mastectomy, lumpectomy scars, hair loss, weight changes and lymphedema, and the review found that a positive body image was linked to smoother work reintegration. This connection is easy to underestimate. Workplaces are social arenas in which appearance, self-presentation and interpersonal confidence all play a role, and a survivor who feels comfortable in her changed body is better equipped to face colleagues and clients without the added burden of self-consciousness.

Taken together, these findings carry a clear message for oncology practice: the path back to work is paved as much in the mind as in the body. The authors argue that psychosocial factors play a crucial role in return-to-work outcomes among breast cancer survivors, and they call for a coordinated, multidisciplinary approach that integrates oncological treatment, mental health support and occupational rehabilitation within a single cancer care pathway. In practical terms, this would mean that surgeons, oncologists, psychologists, psychiatrists, physiotherapists and occupational health specialists work from a shared plan rather than in parallel silos, with employment goals treated as a legitimate component of survivorship care rather than an afterthought once treatment ends.

A particularly forward-looking recommendation from the review is the introduction of early psychosocial assessment within oncological care itself. Rather than waiting until a survivor reports difficulty returning to work, clinicians could systematically screen for anxiety, depression, fatigue and impaired quality of life from the outset of treatment, identifying vulnerable domains while there is still time to intervene. Such assessments would guide the development of individualized survivorship care plans tailored to optimize not only physical functioning but also psychological recovery and occupational reintegration. For a patient flagged as high risk, a care plan might include early referral to psychological support, structured fatigue management, workplace accommodation planning and gradual return-to-work scheduling, all initiated before problems become entrenched.

The broader significance of this work lies in how it reframes what successful cancer care means. As survival rates for breast cancer continue to improve, thanks to earlier detection and more effective therapies, the population of long-term survivors keeps growing, and with it the societal stakes of their full recovery. Employment is central to financial stability, identity, social connection and self-worth, and a survivor who cannot return to work has not fully reclaimed the life the treatment was designed to save. By demonstrating that anxiety, depression, fatigue and social well-being are not peripheral concerns but core determinants of occupational recovery, this systematic review makes a compelling case that mental health support belongs at the heart of cancer survivorship medicine, not at its margins.

Subject of Research: Psychosocial factors influencing return to work in breast cancer survivors

Article Title: Psychosocial factors associated with return-to-work in breast cancer survivors: a systematic review

Article References: Voskanyan, V., Borgogni, F., Marzorati, C., & Pravettoni, G. (2026). Psychosocial factors associated with return-to-work in breast cancer survivors: a systematic review. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-026-06600-y

Image Credits: AI Generated

DOI: 10.1007/s00432-026-06600-y

Keywords: breast cancer, return to work, psychosocial factors, systematic review, anxiety, depression, fatigue, quality of life, resilience, self-efficacy, cancer survivorship, occupational rehabilitation